Medicure (CVE:MPH) Stock Passes Above 50-Day Moving Average – Here’s Why

Medicure Inc. (CVE:MPH)’s stock price crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of C$1.11 and traded as high as C$1.15. Medicure shares last traded at C$1.15, with a volume of 1,000 shares traded.

Medicure Price Performance

The company has a quick ratio of 1.29, a current ratio of 1.02 and a debt-to-equity ratio of 6.90. The business has a 50-day moving average price of C$1.11 and a two-hundred day moving average price of C$1.16. The company has a market capitalization of C$12.00 million, a price-to-earnings ratio of -1.69 and a beta of 0.62.

About Medicure

Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications.